Quarterly Results

INDOCO REMEDIES LTD.

NSE : INDOCOBSE : 532612ISIN CODE : INE873D01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE328.553.6 (+1.11 %)
PREV CLOSE ( ) 324.95
OPEN PRICE ( ) 332.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4911
TODAY'S LOW / HIGH ( )325.25 332.20
52 WK LOW / HIGH ( )308.8 416.95
NSE328.604.55 (+1.4 %)
PREV CLOSE( ) 324.05
OPEN PRICE ( ) 325.70
BID PRICE (QTY) 328.60 (21)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 42066
TODAY'S LOW / HIGH( ) 325.10 329.95
52 WK LOW / HIGH ( )308.3 415
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
4594.2
4817.3
4265
4281.6
Total Expenditure
3965.2
4103.6
3653.3
3634
PBIDT (Excl OI)
629
713.7
611.7
647.6
Other Income
23.5
44.3
4.1
5
Operating Profit
652.5
758.00
615.8
652.6
Interest
100.7
81.1
77.9
86.4
Exceptional Items
-82
NA
NA
NA
PBDT
469.8
676.90
537.9
566.2
Depreciation
243.5
214.1
198.8
176.9
Profit Before Tax
226.3
462.80
339.1
389.3
Tax
70.7
110.4
97.3
131.2
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
155.6
352.40
241.8
258.1
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
155.6
352.40
241.8
258.1
Minority Interest
7.4
-1.6
2.1
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
163
350.8
243.9
258.1
Equity Capital
184.3
184.3
184.3
184.3
Face Value (IN RS)
2
2
2
2
Reserves
NA
NA
NA
NA
Calculated EPS
1.76
3.80
2.64
2.80
Calculated EPS (Annualised)
7.07
15.22
10.58
11.20
No of Public Share Holdings
38019351
38019351
38030687
38065687
% of Public Share Holdings
41.26
41.26
41.27
41.31
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
13.69
14.81
14.34
15.12
PBIDTM%
14.20
15.73
14.43
15.24
PBDTM%
10.22
14.05
12.61
13.22
PBTM%
4.92
9.60
7.95
9.09
PATM%
3.38
7.31
5.66
6.02
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.